Background The contribution of genetic variability to clinical heterogeneity in Parkinson's disease is insufficiently understood. We aimed to investigate the effect of cumulative genetic risk on clinical outcomes. Methods In a single‐center study of 336 patients we genotyped 19 independent suscep…